Comparative bioavailability of two oral formulations of ciprofloxacin
Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J.
Proceedings of the Western Pharmacology Society 46: 134-135
2003
ISSN/ISBN: 0083-8969 PMID: 14699910 Document Number: 559998
Document emailed within 1 workday
Related Documents
Riaz, H.; Goodman, B.; Bashir, S.; Hussain, S.; Mahmood, S.; Malik, F.; Waseem, D.; Raza, S.A.; Mahmood, W.; Alamgeer 2016: Comparative Bioavailability Analysis of Oral Alendronate Sodium Formulations in Pakistan Acta Poloniae Pharmaceutica 73(4): 999-1007Di Nola, F.; Soranzo, M.L. 1983: Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects Minerva Medica 74(6): 239-248
Seth, S.D.; Beotra, A.; Seth, S. 1995: Comparative bioavailability of two brands of ciprofloxacin Journal of the Association of Physicians of India 43(5): 327-330
Verbesselt, R.; Tjandramaga, T.B.; Mullie, A.; De Schepper, P.J. 1978: Comparative bioavailability of two acebutolol formulations Bollettino Chimico Farmaceutico 117(2): 102-106
Suthakaran, C.; Rajaram, S.; Adithan, C. 1992: Comparative bioavailability of two brands of ciprofloxacin: an Indian study International Journal of Clinical Pharmacology Therapy and Toxicology 30(2): 66-68
De Caro, G.; Maggi, L. 1984: Bioavailability in man of oral formulations of flunarizine (drops and capsules) Bollettino Chimico Farmaceutico 123(10): 65S-70S
Lapka, R.; Cepeláková, H.; Rejholec, V.; Franc, Z. 1986: Bioavailability of two oral formulations of triazolam using radioreceptor assay Die Pharmazie 41(4): 256-257
Mendes, G.B.; Franco, L.M.; Moreno, R.A.; Fernandes, A.G.; Muscara, M.N.; de Nucci, G. 1994: Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers International Journal of Clinical Pharmacology and Therapeutics 32(3): 131-135
Hasan, M.M.; Najib, N.M.; Muti, H. 1993: A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration International Journal of Clinical Pharmacology Therapy and Toxicology 31(8): 387-391
Seth, B.L. 1992: Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel Arzneimittel-Forschung 42(2): 120-122
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Jutasompakorn, P.; Kongpatanakul, S.; Pongnarin, P.; Sathirakul, K.; Chatsiricharoenkul, S. 2015: Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study Journal of the Medical Association of Thailand 98(9): 910-915
Baker, B.A.; Reynolds, J.R.; Gleckel, L.; A'Zary, E.; Bodenheimer, M.M. 1988: Comparative bioavailability of two oral sustained-release procainamide products Clinical Pharmacy 7(2): 135-138
Harahap, Y.; Prasaja, B.; Indriati, E.; Lusthom, W.; Lipin 2007: Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers International Journal of Clinical Pharmacology and Therapeutics 45(6): 373-376
Cano, J.P.; Soliva, M.; Hartmann, D.; Ziegler, W.H.; Amrein, R. 1977: Bioavailability from various galenic formulations of flunitrazepam Arzneimittel-Forschung 27(12): 2383-2388
Markiewicz, A.; Semenowicz, K.; Szczyrba, E.; Kocek, B. 1978: Comparison of bioavailability of two dipyridamole formulations Polish Journal of Pharmacology and Pharmacy 30(5): 605-609
Osato, M.S. 1999: Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin Advances in Therapy 16(5): 200-209
Bousquet, E.; Tirendi, S.; Bonina, F.P.; Montenegro, L.; Bianchi, A.; Ciampini, N. 1992: Bioavailability of two formulations of acetylsalicylic acid gums Die Pharmazie 47(8): 607-609
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
González-Peñas, E.; Echeverría, H.C.; Mosquera, J.; Esteras, A.; Bruseghini, L. 2003: Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit Arzneimittel-Forschung 53(11): 786-792